SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-202881
Filing Date
2023-08-03
Accepted
2023-08-03 16:17:59
Documents
15
Period of Report
2023-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d517241d8k.htm   iXBRL 8-K 27220
2 EX-99.1 d517241dex991.htm EX-99.1 72868
7 GRAPHIC g517241g0803065336399.jpg GRAPHIC 4016
  Complete submission text file 0001193125-23-202881.txt   271517

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nuvb-20230803.xsd EX-101.SCH 3877
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nuvb-20230803_def.xml EX-101.DEF 13652
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvb-20230803_lab.xml EX-101.LAB 22564
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvb-20230803_pre.xml EX-101.PRE 14620
9 EXTRACTED XBRL INSTANCE DOCUMENT d517241d8k_htm.xml XML 5303
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 231140321
SIC: 2834 Pharmaceutical Preparations